Literature DB >> 16148174

Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors.

Gabriel Vinderola1, Chantal Matar, Gabriela Perdigon.   

Abstract

The mechanisms by which probiotic bacteria exert their effects on the immune system are not completely understood, but the epithelium may be a crucial player in the orchestration of the effects induced. In a previous work, we observed that some orally administered strains of lactic acid bacteria (LAB) increased the number of immunoglobulin A (IgA)-producing cells in the small intestine without a concomitant increase in the CD4(+) T-cell population, indicating that some LAB strains induce clonal expansion only of B cells triggered to produce IgA. The present work aimed to study the cytokines induced by the interaction of probiotic LAB with murine intestinal epithelial cells (IEC) in healthy animals. We focused our investigation mainly on the secretion of interleukin 6 (IL-6) necessary for the clonal expansion of B cells previously observed with probiotic bacteria. The role of Toll-like receptors (TLRs) in such interaction was also addressed. The cytokines released by primary cultures of IEC in animals fed with Lactobacillus casei CRL 431 or Lactobacillus helveticus R389 were determined. Cytokines were also determined in the supernatants of primary cultures of IEC of unfed animals challenged with different concentrations of viable or nonviable lactobacilli and Escherichia coli, previously blocked or not with anti-TLR2 and anti-TLR4. We concluded that the small intestine is the place where a major distinction would occur between probiotic LAB and pathogens. This distinction comprises the type of cytokines released and the magnitude of the response, cutting across the line that separates IL-6 necessary for B-cell differentiation, which was the case with probiotic lactobacilli, from inflammatory levels of IL-6 for pathogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148174      PMCID: PMC1235795          DOI: 10.1128/CDLI.12.9.1075-1084.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  55 in total

1.  A CD14-independent LPS receptor cluster.

Authors:  K Triantafilou; M Triantafilou; R L Dedrick
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 2.  Lactic acid bacteria and their effect on the immune system.

Authors:  G Perdigón; R Fuller; R Raya
Journal:  Curr Issues Intest Microbiol       Date:  2001-03

3.  Epithelial cells respond to proteolytic and non-proteolytic detachment by enhancing interleukin-6 responses.

Authors:  Tabbi L Miller; Dennis W McGee
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

4.  Characterization of conditions for the primary culture of human small intestinal epithelial cells.

Authors:  M C Aldhous; A N Shmakov; J Bode; S Ghosh
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

5.  IL-10 producing CD14low monocytes inhibit lymphocyte-dependent activation of intestinal epithelial cells by commensal bacteria.

Authors:  Dirk Haller; Patrik Serrant; Genneviève Peruisseau; Christiane Bode; Walter P Hammes; Eduardo Schiffrin; Stephanie Blum
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

6.  Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium.

Authors:  S Naik; E J Kelly; L Meijer; S Pettersson; I R Sanderson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-04       Impact factor: 2.839

7.  Metabolic and functional properties of lactic acid bacteria in the gastro-intestinal ecosystem: a comparative in vitro study between bacteria of intestinal and fermented food origin.

Authors:  D Haller; H Colbus; M G Gänzle; P Scherenbacher; C Bode; W P Hammes
Journal:  Syst Appl Microbiol       Date:  2001-07       Impact factor: 4.022

8.  Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase.

Authors:  Tsuyoshi Shuto; Akira Imasato; Hirofumi Jono; Akihiro Sakai; Haidong Xu; Takahiro Watanabe; Davida D Rixter; Hirofumi Kai; Ali Andalibi; Fred Linthicum; Yue-Ling Guan; Jiahuai Han; Andrew C B Cato; David J Lim; Shizuo Akira; Jian-Dong Li
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

9.  Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant.

Authors:  C Matar; J C Valdez; M Medina; M Rachid; G Perdigon
Journal:  J Dairy Res       Date:  2001-11       Impact factor: 1.904

Review 10.  The Escherichia coli gene pool.

Authors:  G Dougan; A Haque; D Pickard; G Frankel; P O'Goara; J Wain
Journal:  Curr Opin Microbiol       Date:  2001-02       Impact factor: 7.934

View more
  35 in total

1.  Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.

Authors:  Chang Liu; Zhuo-Yang Zhang; Ke Dong; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

3.  Active Hexose Correlated Compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4.

Authors:  Jean-François Mallet; Émilie Graham; Barry W Ritz; Kohei Homma; Chantal Matar
Journal:  Eur J Nutr       Date:  2015-01-18       Impact factor: 5.614

Review 4.  Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.

Authors:  Timothy R Rosean; Van S Tompkins; Guido Tricot; Carol J Holman; Alicia K Olivier; Fenghuang Zhan; Siegfried Janz
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds.

Authors:  Fatou Ndiaye; Tri Vuong; Jairo Duarte; Rotimi E Aluko; Chantal Matar
Journal:  Eur J Nutr       Date:  2011-03-27       Impact factor: 5.614

6.  Mechanisms of Action of Probiotics.

Authors:  Julio Plaza-Diaz; Francisco Javier Ruiz-Ojeda; Mercedes Gil-Campos; Angel Gil
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

7.  The immune-modulating effects of viable Weissella cibaria JW15 on RAW 264.7 macrophage cells.

Authors:  Ho-Eun Park; Kyung-Hyo Do; Wan-Kyu Lee
Journal:  J Biomed Res       Date:  2019-11-28

Review 8.  The gastrointestinal microbiome: a malleable, third genome of mammals.

Authors:  Ian M Carroll; David W Threadgill; Deborah S Threadgill
Journal:  Mamm Genome       Date:  2009-07-21       Impact factor: 2.957

9.  The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity.

Authors:  C Maldonado Galdeano; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2006-02

10.  Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli.

Authors:  V Aparna Sudhakaran; Harsh Panwar; Ritu Chauhan; Raj Kumar Duary; Rahul Kumar Rathore; Virender Kumar Batish; Sunita Grover
Journal:  Genes Nutr       Date:  2013-06-02       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.